Artorn Anuduang

Dr. Artorn Anuduang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2020 in Foods
Verified
Journal Article
Open access
PDF file
AAArtorn Anuduang
Artorn Anuduang
YLYuet Ying Loo
Yuet Ying Loo
SJSomchai Jomduang
Somchai Jomduang
SLSeng Joe Lim
Seng Joe Lim
WAN AIDA BINTI MUSTAPHAWAN AIDA BINTI MUSTAPHA
WAN AIDA BINTI MUSTAPHA
The mulberry silkworm (Bombyx mori L.) is a common edible insect in many countries. However, the impact of thermal processing, especially regarding Thai silkworm powder, is poorly known. We, therefore, determined the optimum time for treatment in hot water and subsequent drying temperatures in the production of silkworm powder. The silkworms exposed to 90 °C water for 0, 5, 10, 15, and 20 min showed values of Total Phenolic Compounds (TPCs), 2,2-Diphenyl-1-picrylhydrazyl free radical scavenging (DPPH) assay, 2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS) assay, and Ferric Reducing Antioxidant Power (FRAP) assay that were significantly (p < 0.05) higher at the 5 min exposure time compared with the other times. The reduction of microorganisms based on log CFU/g counts was ≥3 log CFU/g (99%) at the 5 min treatment. To determine the optimum drying temperature, the silkworms exposed to 90 °C water for 5 min were subjected to a hot-air dryer at 80, 100, 120, and 140 °C. The TPC value was the highest (p < 0.05) at 80 °C. The silkworm powder possessed significantly (p < 0.05) higher DPPH, ABTS radical scavenging ability, and ferric ion reducing capability (FRAP assay) at 80 °C compared with other drying temperatures. This study indicates that shorter exposure times to hot water and a low drying temperature preserve the antioxidant activities. High antioxidant activities (in addition to its known protein and fat content) suggest that silkworms and silkworm powder can make a valuable contribution to human health.

20 March 2024 in Foods
Verified
Journal Article
Open access
PDF file
AAArtorn Anuduang
Artorn Anuduang
WAN AIDA BINTI MUSTAPHAWAN AIDA BINTI MUSTAPHA
WAN AIDA BINTI MUSTAPHA
SLSeng Joe Lim
Seng Joe Lim
SJSomchai Jomduang
Somchai Jomduang
SPSuphat Phongthai
Suphat Phongthai
KBKongsak Boonyapranai
Kongsak Boonyapranai
The angiotensin-I converting enzyme (ACE) plays a pivotal role in hypertension, and while ACE inhibitors are conventional in hypertension management, synthetic medications often carry undesirable side effects. This has spurred interest in alternative ACE inhibitors derived from natural sources, such as edible insects. The silkworm, recognized for its bioactive peptides with potent ACE-inhibitory properties, has emerged as a promising candidate. This study aims to evaluate the acute toxicity and assess the antihypertensive efficacy of crude mature silkworm hydrolysate powder (MSHP) obtained from mature Thai silkworms. Utilizing the commercial protease Alcalase®2.4L, MSHP was administered at various doses, including 50, 100, and 200 mg kg−1, to hypertensive rats. The investigation spans a 14-day period to observe any potential acute toxic effects. Results indicate that MSHP exhibits LD50 values equal to or exceeding 2000 mg kg−1, signifying a low level of acute toxicity. Furthermore, the effective dose for blood pressure reduction in hypertensive rats surpasses 100 mg kg−1 of rat body weight. These findings suggest that MSHP derived from Thai mature silkworms holds promise as a natural antihypertensive food source. The implications of this research extend to the development of functional foods, functional ingredients, and dietary supplements aimed at managing hypertension.

18 March 2024 in International Journal of Food Science and Technology
Verified
Journal Article
Closed access
PDF file
AAArtorn Anuduang
Artorn Anuduang
SLSeng Joe Lim
Seng Joe Lim
SJSomchai Jomduang
Somchai Jomduang
KBKongsak Boonyapranai
Kongsak Boonyapranai
SPSuphat Phongthai
Suphat Phongthai
WMWan Aida Wan Mustapha
Wan Aida Wan Mustapha

25 September 2024 in Foods
Verified
Journal Article
Open access
PDF file
AAArtorn Anuduang
Artorn Anuduang
Sakaewan OunjaijeanSakaewan Ounjaijean
Sakaewan Ounjaijean
RPRewat Phongphisutthinant
Rewat Phongphisutthinant
Pornsiri PitchakarnPornsiri Pitchakarn
Pornsiri Pitchakarn
Supakit ChaipootSupakit Chaipoot
Supakit Chaipoot
KBKongsak Boonyapranai
Kongsak Boonyapranai
The non-enzymatic conjugation of peptides through the Maillard reaction has gained attention as an effective method to enhance biological functions. This study focuses on two conjugate mixtures: crude soy protein hydrolysate (SPH) conjugated with mannose (SPHM) and crude soy protein hydrolysate conjugated with allulose (SPHA). These two mixtures were products of the Maillard reaction, also known as non-enzymatic glycation. In vitro experiments were conducted to evaluate the antioxidant, anti-pancreatic lipase, inhibition of Bovine Serum Albumin (BSA) denaturation, and anti-angiotensin converting enzyme (ACE) activities of these conjugated mixtures. The results indicate that conjugated mixtures significantly enhance the antioxidant potential demonstrated via the DPPH and FRAP assays. SPHA exhibits superior DPPH scavenging activity (280.87 ± 16.39 µg Trolox/mL) and FRAP value (38.91 ± 0.02 mg Trolox/mL). Additionally, both conjugate mixtures, at a concentration of 10 mg/mL, enhance the BSA denaturation properties, with SPHM showing slightly higher effectiveness compared to SPHA (19.78 ± 2.26% and 5.95 ± 3.89%, respectively). SPHA also shows an improvement in pancreatic lipase inhibition (29.43 ± 1.94%) when compared to the SPHM (23.34 ± 3.75%). Furthermore, both the conjugated mixtures and rare sugars exhibit ACE inhibitory properties on their own, effectively reducing ACE activity. Notably, the ACE inhibitory effects of the individual compounds and their conjugate mixtures (SPHM and SPHA) are comparable to those of positive control (Enalapril). In conclusion, SPHM and SPHA demonstrate a variety of bioactive properties, suggesting their potential use in functional foods or as ingredients in supplementary products.

20 November 2024 in Life
Verified
Journal Article
Open access
PDF file
Jiraporn Laoung-onJiraporn Laoung-on
Jiraporn Laoung-on
AAArtorn Anuduang
Artorn Anuduang
CSChalermpong Saenjum
Chalermpong Saenjum
SSSomdet Srichairatanakool
Somdet Srichairatanakool
KBKongsak Boonyapranai
Kongsak Boonyapranai
Sakaewan OunjaijeanSakaewan Ounjaijean
Sakaewan Ounjaijean
Obesity, a major global health concern, is represented by an accumulation of adipose tissue and body mass, leading to a higher incidence of non-communicable diseases (NCDs). Camellia sinensis var. assamica, known as cha-miang, contains catechin and its derivatives, which have been reported to affect several health-related concerns such as anti-cancer, anti-inflammatory, anti-hyperlipidemia, and against cardiovascular disease. The research aimed to examine the anti-obesity and insulin resistance effects of fresh cha-miang extract (CME) and fermented cha-miang extract (FCME), and to investigate the anti-obesity and anti-diabetic effects of CME and FCME in obese rats generated by a high-fat diet. The extracts demonstrated significant antioxidant potential, with CME demonstrating greater DPPH radical scavenging activity, whereas FCME excelled in ABTS radical scavenging. In the animal model, CME and FCME significantly reduced body weight, plasma insulin levels, insulin resistance, and accumulation of fat compared to the obese control group. Moreover, plasma biochemical analysis indicated that both extracts enhanced lipid profiles by reducing cholesterol, triglycerides, and LDL-cholesterol levels, while elevating HDL-cholesterol. Histological analysis revealed decreased hepatic fat accumulation, especially when extracts were concurrently treated with metformin. The research indicates that CME and FCME, especially in conjunction with metformin, have potential anti-obesity and anti-insulin resistance benefits attributed to their abundant polyphenolic content and antioxidant characteristics. This indicates that cha-miang may serve as an effective option for the management of obesity and metabolic diseases.

29 May 2025 in Biology
Verified
Journal Article
Open access
PDF file
Jiraporn Laoung-onJiraporn Laoung-on
Jiraporn Laoung-on
AAArtorn Anuduang
Artorn Anuduang
CSChalermpong Saenjum
Chalermpong Saenjum
KRKittipan Rerkasem
Kittipan Rerkasem
SSSomdet Srichairatanakool
Somdet Srichairatanakool
Sakaewan OunjaijeanSakaewan Ounjaijean
Sakaewan Ounjaijean
Background: Type 2 diabetes mellitus is a chronic metabolic disease related to obesity and high-calorie diets, which presents hyperglycemia and insulin resistance. The management of diabetes can cause a rise in financial burden and synthetic medications can have adverse effects. This study aims to investigate the anti-diabetic and antioxidant activity of SHE, CME, and SHE in diabetic rats. Methods: Seventy-eight rats were randomly assigned to the following 13 groups (n = 6): N-DW, D-DW, D-M, D-S, D-C, D-F, D-SC, D-SF, D-SM, D-CM, D-FM, D-SCM, and D-SFM, for 8 weeks. Body weight, relative organ weight, blood glucose, insulin resistance, and plasma biomarkers related to diabetes were determined. Results: Diabetic rats had a significantly decreased body weight, RBC-GHS, liver-GHS, and RBC-SOD activity and a significantly increased relative organ weight, blood glucose levels, insulin levels, insulin resistance, HbA1C, TC, TG, LDL, plasma-MDA, and liver-MDA when compared to the N-DW group. However, plant supplementation and metformin improved diabetes-related parameters, especially the combination of CME or FCME with SHE and metformin, which showed the greatest potential for improving diabetic conditions. (4) Conclusions: The research indicates that CME or FCME conjugated with SHE and metformin demonstrates the greatest potential for enhancing diabetic conditions, confirming positive synergism. These findings suggest that the combination of CME or FCME with SHE and metformin may be effective for diabetic treatment.